Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Mar;33(3):696–700. doi: 10.1128/jcm.33.3.696-700.1995

Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus.

M McCullough 1, B Ross 1, P Reade 1
PMCID: PMC228016  PMID: 7751379

Abstract

During the course of a study of oral Candida albicans strains from 60 human immunodeficiency virus-infected patients over a 2.5-year period, 18 of the 295 C. albicans isolates had genomes that failed to hybridize with a C. albicans-specific DNA probe (27A). These strains were germ tube positive and chlamydospore positive and were identified as C. albicans by the ID 32C test (API Systems, Montlieu, France). These strains were analyzed for the presence of two other C. albicans-specific DNA segments by PCR. The first was a C. albicans 1,348-bp species-specific sequence, and the second was a 1,059-bp C. albicans repetitive element. The probe 27A-hybridizing strains yielded PCR products which differed from those of the nonhybridizing strains. Five of these genetically atypical C. albicans strains and 98 of the C. albicans strains were then analyzed for purported virulence factors. The genetically atypical C. albicans strains, in comparison with typical C. albicans strains, produced greater amounts of extracellular proteinase (P = 0.038, Student's t test), adhered to a greater degree to buccal epithelial cells (P = 0.018, Student's t test), and were less susceptible to the antifungal drug 5-flucytosine (P = 0.0003, Mann-Whitney test). Analysis of these strains with other common antifungal drugs showed no statistically significant variation in susceptibility. The results of this study indicated that these genetically atypical C. albicans strains possess increased virulence in comparison with typical C. albicans strains.

Full Text

The Full Text of this article is available as a PDF (299.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brawner D. L., Cutler J. E. Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome. J Clin Microbiol. 1989 Jun;27(6):1335–1341. doi: 10.1128/jcm.27.6.1335-1341.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. De Bernardis F., Agatensi L., Ross I. K., Emerson G. W., Lorenzini R., Sullivan P. A., Cassone A. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. J Infect Dis. 1990 Jun;161(6):1276–1283. doi: 10.1093/infdis/161.6.1276. [DOI] [PubMed] [Google Scholar]
  3. Douglas L. J. Adhesion of pathogenic Candida species to host surfaces. Microbiol Sci. 1985 Aug;2(8):243–247. [PubMed] [Google Scholar]
  4. Douglas L. J. Candida proteinases and candidosis. Crit Rev Biotechnol. 1988;8(2):121–129. doi: 10.3109/07388558809150541. [DOI] [PubMed] [Google Scholar]
  5. Ghannoum M. A., Abu-Elteen K. H. Pathogenicity determinants of Candida. Mycoses. 1990 Jun;33(6):265–282. doi: 10.1111/myc.1990.33.6.265. [DOI] [PubMed] [Google Scholar]
  6. Ghannoum M., Abu Elteen K. Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans. J Med Vet Mycol. 1986 Oct;24(5):407–413. doi: 10.1080/02681218680000621. [DOI] [PubMed] [Google Scholar]
  7. Kondoh Y., Shimizu K., Tanaka K. Proteinase production and pathogenicity of Candida albicans. II. Virulence for mice of C. albicans strains of different proteinase activity. Microbiol Immunol. 1987;31(11):1061–1069. doi: 10.1111/j.1348-0421.1987.tb01338.x. [DOI] [PubMed] [Google Scholar]
  8. Korting H. C., Ollert M., Georgii A., Fröschl M. In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus. J Clin Microbiol. 1988 Dec;26(12):2626–2631. doi: 10.1128/jcm.26.12.2626-2631.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kwon-Chung K. J., Riggsby W. S., Uphoff R. A., Hicks J. B., Whelan W. L., Reiss E., Magee B. B., Wickes B. L. Genetic differences between type I and type II Candida stellatoidea. Infect Immun. 1989 Feb;57(2):527–532. doi: 10.1128/iai.57.2.527-532.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lasker B. A., Page L. S., Lott T. J., Kobayashi G. S. Isolation, characterization, and sequencing of Candida albicans repetitive element 2. Gene. 1992 Jul 1;116(1):51–57. doi: 10.1016/0378-1119(92)90628-3. [DOI] [PubMed] [Google Scholar]
  11. Macdonald F., Odds F. C. Inducible proteinase of Candida albicans in diagnostic serology and in the pathogenesis of systemic candidosis. J Med Microbiol. 1980 Aug;13(3):423–435. doi: 10.1099/00222615-13-3-423. [DOI] [PubMed] [Google Scholar]
  12. Mahrous M., Sawant A. D., Pruitt W. R., Lott T., Meyer S. A., Ahearn D. G. DNA relatedness, karyotyping and gene probing of Candida tropicalis, Candida albicans and its synonyms Candida stellatoidea and Candida claussenii. Eur J Epidemiol. 1992 May;8(3):444–451. doi: 10.1007/BF00158581. [DOI] [PubMed] [Google Scholar]
  13. McCullough M. J., Ross B. C., Dwyer B. D., Reade P. C. Genotype and phenotype of oral Candida albicans from patients infected with the human immunodeficiency virus. Microbiology. 1994 May;140(Pt 5):1195–1202. doi: 10.1099/13500872-140-5-1195. [DOI] [PubMed] [Google Scholar]
  14. Oren I., Manavathu E. K., Lerner S. A. Isolation and characterization of a species-specific DNA probe for Candida albicans. Nucleic Acids Res. 1991 Dec;19(25):7113–7116. doi: 10.1093/nar/19.25.7113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Samaranayake L. P. Oral mycoses in HIV infection. Oral Surg Oral Med Oral Pathol. 1992 Feb;73(2):171–180. doi: 10.1016/0030-4220(92)90191-r. [DOI] [PubMed] [Google Scholar]
  16. Scherer S., Stevens D. A. A Candida albicans dispersed, repeated gene family and its epidemiologic applications. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1452–1456. doi: 10.1073/pnas.85.5.1452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Scherer S., Stevens D. A. Application of DNA typing methods to epidemiology and taxonomy of Candida species. J Clin Microbiol. 1987 Apr;25(4):675–679. doi: 10.1128/jcm.25.4.675-679.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Schmid J., Odds F. C., Wiselka M. J., Nicholson K. G., Soll D. R. Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting. J Clin Microbiol. 1992 Apr;30(4):935–941. doi: 10.1128/jcm.30.4.935-941.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Shimizu K., Kondoh Y., Tanaka K. Proteinase production and pathogenicity of Candida albicans. I. Invasion into chorioallantoic membrane by C. albicans strains of different proteinase activity. Microbiol Immunol. 1987;31(11):1045–1060. doi: 10.1111/j.1348-0421.1987.tb01337.x. [DOI] [PubMed] [Google Scholar]
  20. Sullivan D., Bennett D., Henman M., Harwood P., Flint S., Mulcahy F., Shanley D., Coleman D. Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. J Clin Microbiol. 1993 Aug;31(8):2124–2133. doi: 10.1128/jcm.31.8.2124-2133.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tavitian A., Raufman J. P., Rosenthal L. E. Oral candidiasis as a marker for esophageal candidiasis in the acquired immunodeficiency syndrome. Ann Intern Med. 1986 Jan;104(1):54–55. doi: 10.7326/0003-4819-104-1-54. [DOI] [PubMed] [Google Scholar]
  22. Torssander J., Morfeldt-Månson L., Biberfeld G., Karlsson A., Putkonen P. O., Wasserman J. Oral candida albicans in HIV infection. Scand J Infect Dis. 1987;19(3):291–295. doi: 10.3109/00365548709018473. [DOI] [PubMed] [Google Scholar]
  23. Wickes B. L., Golin J. E., Kwon-Chung K. J. Chromosomal rearrangement in Candida stellatoidea results in a positive effect on phenotype. Infect Immun. 1991 May;59(5):1762–1771. doi: 10.1128/iai.59.5.1762-1771.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES